Last reviewed · How we verify

NCT02851810: MONRADO2

Oculomotor Markers and Attachment in Adolescents

Completed NA Last updated 2 October 2018
What this trial tests

NA trial testing oculomotor parameter recording in Emotion Dysregulation in 124 participants. Completed in 8 June 2017.

Timeline
19 December 2013
Primary endpoint
8 June 2017
8 June 2017

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Besancon
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment124
Start date19 December 2013
Primary completion8 June 2017
Estimated completion8 June 2017
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Besancon

Who can join

Adults 13 to 20, any sex, with Emotion Dysregulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to identify specific visual scanning patterns of attachment pictures in adolescent with different attachment style.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. How do adolescents regulate distress according to attachment style? A combined eye-tracking and neurophysiological approach.
    Szymanska M, Monnin J, Tio G, Vidal C, et al · · 2019 · cited 6× · PMID 30165119 · DOI 10.1016/j.pnpbp.2018.08.019
  2. Attachment-based parent-adolescent interaction linked to visual attention and autonomic arousal to distress and comfort stimuli.
    Schneider M, Obsuth I, Szymanska M, Mathieu J, et al · · 2022 · cited 1× · PMID 35501885 · DOI 10.1186/s40359-022-00821-9

Verify or expand the search:

Other recruiting trials for Emotion Dysregulation

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Besancon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02851810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing